A review on risk assessment of formulation development and technology transfer of COVID-19 vaccines
Vitae (Medellín); 29 (2), 2022
Background: COVID-19 pandemic situation made the pharmaceutical companies develop the vaccine with different formulations in a short period. Objectives: The main objective of the review is to focus on different types of vaccine formulations available globally and the i...